Taste Masking of Propiverine Hydrochloride by Conversion to Its Free Base
スポンサーリンク
概要
- 論文の詳細を見る
The aim of the present study was to mask the bitterness of propiverine hydrochloride (P-4) by converting it to propiverine free base. Fine granules comprising the free base, which was converted from P-4 by desalination, were prepared. By using Fourier transform infrared spectroscopy, thermogravimetry-differential thermal analysis, and powder X-ray diffraction spectra, we confirmed that P-4 had been converted into propiverine free base by desalination during the manufacturing process. Furthermore, the conversion into free base appeared to result in decreased solubility, and both the taste testing sensor and tasting volunteers determined that it masked the bitterness of P-4. On using the gustatory sensation test, the bitterness of the P-4 fine granules was confirmed to be weakened. The dissolution rate and bioavailability of fine granules of the free base were compared with tablets of P-4. The dissolution rate and bioavailability of the fine granules and tablets were almost the same. We successfully masked the taste of P-4 by converting it into free base using a manufacturing process that was suitable for commercial manufacturing.
著者
-
Ozeki Tetsuya
Graduate School Of Pharmaceutical Sciences Nagoya City University
-
Ogata Tetsuo
Formulation Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd.
-
Koide Atsuo
Manufacturing Technology Department, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd.
-
Kinoshita Masahiro
Formulation Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd.
関連論文
- Treatment of Rat Brain Tumors Using Sustained-Release of Camptothecin from Poly(lactic-co-glycolic acid) Microspheres in a Thermoreversible Hydrogel
- Taste Masking of Propiverine Hydrochloride by Conversion to Its Free Base
- Preparation of spray-dried microparticles using Gelucire 44/14 and porous calcium silicate or spherical microcrystalline cellulose to enhance transport of water-insoluble pranlukast hemihydrate across Caco-2 monolayers